Acorda Therapeutics
ACOR
#10361
Rank
S$1.09 M
Marketcap
$0.88
Share price
0.00%
Change (1 day)
-95.67%
Change (1 year)

Revenue for Acorda Therapeutics (ACOR)

Revenue in 2024 (TTM): S$0.15 Billion

According to Acorda Therapeutics 's latest financial reports the company's current revenue (TTM ) is S$0.15 Billion. In 2023 the company made a revenue of S$0.15 Billion a decrease over the revenue in the year 2022 that were of S$0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acorda Therapeutics from 2006 to 2024

2008201220162020$0.2B$0.4B$0.6B$0.8Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) S$0.15 B0.18%
2023 S$0.15 B-2.26%
2022 S$0.15 B-8.91%
2021 S$0.17 B-13.77%
2020 S$0.20 B-21.99%
2019 S$0.25 B-59.72%
2018 S$0.64 B-18.15%
2017 S$0.78 B4.63%
2016 S$0.75 B7.91%
2015 S$0.69 B31.37%
2014 S$0.53 B24.46%
2013 S$0.42 B13.98%
2012 S$0.37 B-1.18%
2011 S$0.37 B53.82%
2010 S$0.24 B220.54%
2009 S$76.75 M12.22%
2008 S$68.39 M20.37%
2007 S$56.82 M35.48%
2006 S$41.93 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$0.83 B 438.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.68 B 2,280.01%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.28 M-99.17%๐Ÿ‡ฉ๐Ÿ‡ช Germany
S$2.19 B 1,318.20%๐Ÿ‡บ๐Ÿ‡ธ USA